Case report: Persistent COVID-19 in a patient with B cell lymphoma refractory to antiviral treatment due to resistance to Remdesivir
Background: There is a significant concern of the pandemic impact of SARS-CoV-2 infection in immunocompromised patients. These patients can develop long COVID-19 due to impairment of cellular and humoral immunity. On the other hand, prolonged infection can lead to mutations in the SARS CoV-2 genome...
Saved in:
| Main Authors: | Luiz Eduardo Ceccon Calil de Assumpção, Bruno Graciano Ponce Romeo, João Carlos de Campos Guerra, Luis Fernando Aranha Camargo, Marcelo Akira Nagaoka, Deyvid Emanuel Amgarten, Erick Gustavo Dorlass, Roberta Cardoso Petroni, Afonso Celso Almeida Cardoso, Renato de Mello Ruiz, Carolina Devite Bittante, Vanessa Damazio Teich, João Renato Rebello Pinho, André Mario Doi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | IDCases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S221425092500054X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study
by: Nithish Sattoju, et al.
Published: (2023-07-01) -
Immunological Effects of Remdesivir on Colon Cancer Cell Line
by: Alaa Hameed, et al.
Published: (2025-04-01) -
Synthesis of Radioisotope 14C Labelled Remdesivir
by: Zhi-yang YU, et al.
Published: (2025-02-01) -
Efficacy and safety of remdesivir and favipiravir in COVID-19 patients – A systematic review and meta-analysis
by: Piyush Vatsha, et al.
Published: (2025-05-01) -
Efficacy and Safety of Remdesivir for the Treatment of Patients with COVID-19: A Systematic Review
by: Anupa Thampy, et al.
Published: (2025-04-01)